Navigation Links
Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
Date:4/8/2009

BALTIMORE, April 8 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, has established a UK subsidiary, Champions Biotechnology UK Ltd. (CBUK), to expand its personalized oncology business. Guy Malchi has been appointed General Manager of the UK subsidiary, which will also have a branch in Israel.

"We have been experiencing an increase in activity in all of our business, particularly in our personalized oncology service. Significantly, much of the increased activity in our personalized oncology business is from leading oncologists in Europe as they recognize the enhancement to their practice that is available by utilizing Champions' services. Champions Biotechnology UK Ltd. will enable our services to be accessible to many more physicians in Europe and beyond. The growing trend of medical tourism in Israel has prompted us to establish a branch in Israel to offer our services there as well," said Doug Burkett, PhD, President of Champions Biotechnology, Inc.

Dr. Burkett continued, "I am delighted to welcome Guy Malchi on board as he transitions from consultant to take on the leadership role for CBUK. He will also lead our corporate development efforts, which are focused on in-licensing and co-development of oncology drug candidates that have proven successful in our Biomerk Tumorgraft(TM) platform. Guy's expertise in strategy implementation and business development are a valuable benefit to Champions."

"I am thrilled to join Champions Biotechnology to help it realize its high potential," said Mr. Malchi. "I was drawn to the unique interaction between personalized medicine and drug development, and I look forward to contributing to the firm's success."

Guy Malchi, MBA brings more than twelve years
'/>"/>

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
6. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
7. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
8. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
9. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
10. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
11. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced the approval of all of its,"fir...he District of Delaware,(the "Bankruptcy Court"). ...lief under Chapter 11 of the United States Bankrup... orders issued by the Bankruptcy Court allow the c...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Bio...dministration (SFDA) has approved the,investigatio...n project,(Nodlin), an innovative insulin formulat...olaxy to initiate its first phase I clinical study... of high blood glucose and poor,metabolism. The co...
(Date:11/24/2009)...ary efficacy endpoint has been met for patients wi...cer, , QUEBEC CITY, Nov. 24 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced positive efficacy data from a Ph...njugate, AEZS-108 (formerly AN-152), in patients w...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...eye exams and care for rural Indians , , - Lever...HYDERABAD, India, March 11 Satyam Computer Servic...ting and information technology services provider,...he LV Prasad Eye Institute, with a Consumer Health...ch provides expert and affordable eye care to Indi...
...epartment in State of Qatar to Introduce State-of-...gy , , DOHA, Qatar, March 11 One of the leading ... advanced radiotherapy devices from Varian Medical... technology for fast and precise treatments. Al Am...-old linear accelerators from another manufacturer...
...roid test market expands to EU, LATAM and Africa ,... Devices Canada, Inc. announces the immediate avai... TSH, the first clinical indicator of hypothyroidi...it has only been offered in the U.S. as an FDA-reg... physician office labs. With the CE mark indicatin...
Other Biology Technology:Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 2Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 3Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program 4Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems 2Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems 3SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests 2
(Date:11/23/2009)...CINCINNATINew research presents strong evidence th... to both outdoor traffic-related pollution and ind... than one or the other exposure alone. , Envir...ncinnati (UC) College of Medicine have shown that ...lated particles and indoor endotoxin during early ...
(Date:11/23/2009)... A new study by the Wildlife Conservation Society...rge swamp in the Republic of Congopart of the "mot... last yearare becoming increasingly threatened by ...dy recommends protection of the swamp forests adja...eserve after recent surveys confirmed that high de...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available fo...e herd infected with the virus. The vaccination ma...e herd diagnosed with the pandemic flu., Iowa St...science, developed the vaccine this summer and has... in Iowa, Kansas and Illinois for several weeks.,...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2FDA Announces Plans for LASIK Quality of Life Project 59587 1FDA Announces Plans for LASIK Quality of Life Project 59587 2FDA Announces Plans for LASIK Quality of Life Project 59587 3AMA Medicare Campaign Kicks Off With New TV Ads 59585 1AMA Medicare Campaign Kicks Off With New TV Ads 59585 2AMA Medicare Campaign Kicks Off With New TV Ads 59585 3Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 1Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 2
...of a new study suggest that bacteria that cause di...ness can turn the genes that make them infectious ... like Yersinia pestis and E. coli, do this may one... expression of these genes, thereby making the bac...author and a research associate in microbiology at...
...liver renews itself may be simpler than what scien... the April 13 issue of The Journal of Biological C...rkings of cells from regenerating livers that coul...ers regrow in patients with liver diseases such as...ver is one of the few organs in the body that can ...
..., considered by many to be creepy-crawly, are givi... species of whip spiders, or amblypygids, mothers ...ck together until they reach sexual maturity, and ...ior for these arachnids long-thought to be purely ... researcher. , Social behavior is extremely rare...
Other Biology News:Bacteria control how infectious they become, study finds 2Bacteria control how infectious they become, study finds 3Liver regeneration may be simpler than previously thought 2Liver regeneration may be simpler than previously thought 3A rarity among arachnids, whip spiders have a sociable family life 2A rarity among arachnids, whip spiders have a sociable family life 3
Gel Loading Dye (Bromophenol Blue/Glycerol) from Mo Bio Laboratories, Inc.
Toxoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
EBV-VCA IgA ELISA Kit, Single from Bio-Quant Inc.
Biology Products: